HK1003031A1 - Condensed pyrimidine derivatives and their use as angiotensine ii antagonists - Google Patents

Condensed pyrimidine derivatives and their use as angiotensine ii antagonists Download PDF

Info

Publication number
HK1003031A1
HK1003031A1 HK98102075A HK98102075A HK1003031A1 HK 1003031 A1 HK1003031 A1 HK 1003031A1 HK 98102075 A HK98102075 A HK 98102075A HK 98102075 A HK98102075 A HK 98102075A HK 1003031 A1 HK1003031 A1 HK 1003031A1
Authority
HK
Hong Kong
Prior art keywords
compound
formula
methyl
pyrimidin
pharmaceutically acceptable
Prior art date
Application number
HK98102075A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1003031B (en
Inventor
Watson Ellingboe John
Nikaido Madelene
Franroz Bagli Jehan
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/782,025 external-priority patent/US5149699A/en
Priority claimed from GB9207560A external-priority patent/GB2265899A/en
Priority claimed from US07/901,485 external-priority patent/US5256654A/en
Application filed by Wyeth filed Critical Wyeth
Publication of HK1003031B publication Critical patent/HK1003031B/en
Publication of HK1003031A1 publication Critical patent/HK1003031A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98102075A 1991-10-24 1998-03-12 Condensed pyrimidine derivatives and their use as angiotensine ii antagonists HK1003031A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/782,025 US5149699A (en) 1991-10-24 1991-10-24 Substituted pyridopyrimidines useful as antgiotensin II antagonists
GB9207560 1992-04-07
GB9207560A GB2265899A (en) 1992-04-07 1992-04-07 Substituted pyrimidines
US901485 1992-06-25
US07/901,485 US5256654A (en) 1991-10-24 1992-06-25 Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
US782025 1996-12-30

Publications (2)

Publication Number Publication Date
HK1003031B HK1003031B (en) 1998-09-30
HK1003031A1 true HK1003031A1 (en) 1998-09-30

Family

ID=27266132

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102075A HK1003031A1 (en) 1991-10-24 1998-03-12 Condensed pyrimidine derivatives and their use as angiotensine ii antagonists

Country Status (21)

Country Link
EP (1) EP0539086B1 (cs)
JP (1) JP3240192B2 (cs)
KR (1) KR100286624B1 (cs)
CN (2) CN1039324C (cs)
AT (1) ATE161537T1 (cs)
AU (1) AU653635B2 (cs)
CA (1) CA2080705C (cs)
DE (1) DE69223734T2 (cs)
DK (1) DK0539086T3 (cs)
ES (1) ES2111617T3 (cs)
FI (1) FI103971B1 (cs)
GR (1) GR3025926T3 (cs)
HK (1) HK1003031A1 (cs)
HU (2) HU218786B (cs)
IL (1) IL103436A (cs)
LV (1) LV12047B (cs)
NO (1) NO301275B1 (cs)
SG (1) SG47626A1 (cs)
SK (1) SK280292B6 (cs)
TW (1) TW226375B (cs)
UA (1) UA27748C2 (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE250043T1 (de) * 1991-11-18 2003-10-15 Du Pont Tetrazolylphenylborsäureintermediate zur synthese von aii rezeptor antagonisten
ATE175413T1 (de) * 1993-03-24 1999-01-15 American Home Prod Substituierte pyridopyrimidine als antihypertensiva
DK0782996T3 (da) * 1994-09-20 1999-09-20 Wakunaga Seiyaku Kk Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AR033390A1 (es) 2000-08-22 2003-12-17 Novartis Ag Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
GB0402262D0 (en) 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
SG153831A1 (en) 2004-03-17 2009-07-29 Novartis Ag Use of renin inhibitors in therapy
US20080085914A1 (en) 2004-10-08 2008-04-10 David Louis Feldman Use Of Organic Compounds
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
WO2008104580A1 (en) 2007-03-01 2008-09-04 Probiodrug Ag New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DK2160190T3 (en) * 2007-06-07 2016-01-11 Sigma Tau Ind Farmaceuti 5 BETA 14 BETA-androstane FOR USE FOR THE TREATMENT OF DISEASES CAUSED BY ORGAN FIBROSIS
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2011029920A1 (en) 2009-09-11 2011-03-17 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
SG183229A1 (en) 2010-03-10 2012-09-27 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
JP5945532B2 (ja) 2010-04-21 2016-07-05 プロビオドルグ エージー グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
AP2014007766A0 (en) 2011-12-15 2014-07-31 Takeda Pharmaceuticals Usa Inc Combination os azilsartan and chlorthlidone for treating hypertension black patients
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治療胃腸道病症的組成物
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
EP0515535A4 (en) * 1990-02-13 1996-01-17 Merck & Co Inc Angiotensin ii antagonists incorporating a substituted benzyl element
IL100917A0 (en) 1991-02-16 1992-11-15 Fisons Plc Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
CN1175414A (zh) 1998-03-11
SG47626A1 (en) 1998-04-17
HU211915A9 (en) 1996-01-29
IL103436A0 (en) 1993-03-15
KR100286624B1 (ko) 2001-05-02
CA2080705C (en) 2002-12-03
FI924397A0 (fi) 1992-09-30
GR3025926T3 (en) 1998-04-30
EP0539086A3 (en) 1993-06-16
ES2111617T3 (es) 1998-03-16
SK322192A3 (en) 1999-11-08
DE69223734D1 (de) 1998-02-05
AU653635B2 (en) 1994-10-06
CN1039324C (zh) 1998-07-29
NO924121D0 (no) 1992-10-23
HU218786B (hu) 2000-12-28
JPH05222039A (ja) 1993-08-31
NO924121L (no) 1993-04-26
TW226375B (cs) 1994-07-11
LV12047B (en) 1998-08-20
CN1072682A (zh) 1993-06-02
HU9203161D0 (en) 1992-12-28
ATE161537T1 (de) 1998-01-15
FI924397L (fi) 1993-04-25
FI103971B (fi) 1999-10-29
AU2607992A (en) 1993-04-29
NO301275B1 (no) 1997-10-06
LV12047A (lv) 1998-05-20
JP3240192B2 (ja) 2001-12-17
EP0539086A2 (en) 1993-04-28
UA27748C2 (uk) 2000-10-16
IL103436A (en) 1996-03-31
SK280292B6 (sk) 1999-11-08
FI103971B1 (fi) 1999-10-29
DE69223734T2 (de) 1998-04-16
EP0539086B1 (en) 1997-12-29
KR930007949A (ko) 1993-05-20
CA2080705A1 (en) 1993-04-25
DK0539086T3 (da) 1998-02-02
HUT62893A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
EP0539086B1 (en) Condensed pyrimidine derivatives and their use as angiotensine II antagonists
US5149699A (en) Substituted pyridopyrimidines useful as antgiotensin II antagonists
HK1003031B (en) Condensed pyrimidine derivatives and their use as angiotensine ii antagonists
US5225414A (en) Substituted azoles, a process for their preparation, and their use
EP0611368B1 (en) Substituted aminopyrimidines as angiotensin ii antagonists
JP3260415B2 (ja) アンギオテンシンii拮抗作用を有する複素環化合物
EP0445811B1 (en) Nitrogen-containing heterocyclic compounds, their production and use
US5466692A (en) Substituted pyridopyrimidines and antihypertensives
WO1993008170A1 (en) Substituted heterocycles as angiotensin ii antagonists
US5330989A (en) Heterocycles substituted with biphenyl-3-cyclobutene-1,2-dione derivatives
US5283242A (en) Substituted benzimidazoles and quinazolines as antihypertensives
US5256654A (en) Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
US4596799A (en) 9H-pyrrolo[2,1-c]-1,2,4-triazolo[4,3-a][1,4]benzodiazepines
EP0618207B1 (en) Substituted pyridopyrimidines as antihypertensives
GB2265899A (en) Substituted pyrimidines
US6096754A (en) N-3 substituted pyrimidin-4-ones with AII antagonistic activity
HK1011358B (en) Substituted pyridopyrimidines as antihypertensives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20041014